Implementation and Evaluation of "Mindfulness-Based Cognitive Therapy" in a Health Care Region in Flanders: a Randomized Clinical Trial
Study Details
Study Description
Brief Summary
Research project regarding the possibility to implement and the efficacy of a non-drug, psychotherapeutic intervention (MBCT), in preventing relapse/recurrence of depression.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
This trial is based on the following publications:
Teasdale JD, Segal ZV, Williams JMG, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse / recurrence in major depression by Mindfulness-Based Cognitive Therapy. Journal of Consulting and Clinical Psychology 2000; 68(4): 615-623.
Ma SH, Teasdale JD. Mindfulness-Based Cognitive Therapy for depression: replication and exploration of differential relapse prevention effects. Journal of Consulting and Clinical Psychology 2004; 72(1): 31-40.
Study Design
Outcome Measures
Primary Outcome Measures
- Feasibility to implement MBCT in a Flemish region []
- Relapse/recurrence of depression after approximately 12 months []
Secondary Outcome Measures
- Health status []
- Quality of life []
- Coping []
- Fear []
- Rumination []
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age: 18 years and above
-
place of residence in accordance with a well-defined region (pilot study)
-
given informed consent
-
diagnosis of recurrent depression (DSM-IV-TR)
-
at least 3 depressive episodes in the anamnesis (depression: either primary or secondary diagnosis)
-
last depressive episode at least 8 weeks ago (DSM-IV-TR)
-
absence of a present depressive episode
-
history of treatment by an antidepressant medication
-
HRSD-score <14 at baseline assessment (Hamilton Rating Scale for Depression, HRSD-17)
-
absence of exclusion criteria
Exclusion Criteria:
-
based on DSM-IV-TR: current diagnosis of any of the following psychiatric disorders: lifetime mood disorder, chronic depression, dysthymia, current substance abuse, obsessive-compulsive disorder, bipolar disorder, acute psychosis, cognitive disorder, organic mental disorder, pervasive developmental disorder, mental retardation, primary diagnosis of axis-II-disorder, at risk for suicide
-
Extended experience with zen- or vipassana meditation (or mindfulness) in the past or
-
more than 1 hour practice of zen- or vipassana meditation (or mindfulness) per week during the last 8 weeks
-
other meditation practices except for MBCT during the training
-
more than 1 psychiatric consultation per 3-4 weeks during the training and follow-up
-
intensive psychotherapy during the training and follow-up
-
schizophrenia or schizoaffective disorder in the anamnesis
-
physical problems which make it difficult to participate in the programme
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University Hospital Ghent | Ghent | Belgium | 9000 |
Sponsors and Collaborators
- University Hospital, Ghent
- Ministry of the Flemish Community
Investigators
- Principal Investigator: Kees van Heeringen, MD, PhD, University Hospital, Ghent
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- 2005/195